Retatrutide vs Semaglutide in Type 2 Diabetes: Ongoing Clinical Trial Evaluation | Retatrutide News

A clinical trial is comparing retatrutide and semaglutide in Type 2 Diabetes patients with inadequate glycemic control. The study, lasting 26 months, is...
Clinical Trials · October 22, 2026